BioMarin Announces Record Revenues in Second Quarter 2022; Increases Full-year 2022 Top and Bottom-line Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/10/2026

1. SKHY
2. META
3. PEP
4. USO
5. SPY
6. DAL
7. WRAP
8. CRCL
9. NRIX
10. KBH

Go back to BioMarin Announces Record Revenues in Second Quarter 2022; Increases Full-year 2022 Top and Bottom-line Guidance

BioMarin Pharma (BMRN) Tops Q2 EPS by 12c, Offers Guidance

August 3, 2022 4:05 PM EDT

BioMarin Pharma (NASDAQ: BMRN) reported Q2 EPS of $0.15, $0.12 better than the analyst estimate of $0.03. Revenue for the quarter came in at $533.8 million versus the consensus estimate of $520.35 million.

GUIDANCE:

BioMarin Pharma sees FY2022 revenue of $2.06-2.16 billion, versus the consensus of... More